ClinicalTrials.Veeva

Menu

Survey on the Clinical Assessment of the Psychological Status of a Patient Over 75 Years Old in Oncology During the Realization of the G8 Score (CADEPO)

H

Hopital Nord Franche-Comte

Status

Completed

Conditions

Depression

Study type

Observational

Funder types

Other

Identifiers

NCT05681793
2022-A02329-34

Details and patient eligibility

About

The goal of this observational study is to make a statement concerning the identification of depressive symptoms at the time of the realization of the G8 score in patients over 75 with cancer and followed in oncology.

The main question it aims to answer are:

  • Compare the medical hetero-evaluation of depressive symptoms via the G8 "neuro-psychiatric disorders" item score with a self-evaluation via the GDS-15 score
  • Evaluate the number of patients over 75 treated with antidepressants
  • Evaluate the proportion of patients with depressive symptoms according to the predisposing factors
  • Compare the number of patients followed in oncogeriatrics over the period from 01/01/2022 to 02/28/2022 and the period from 01/01/2023 to 02/28/2023

Participants will complete a self-questionnaire (GDS-15 score) as well as a socio-demographic sheet.

Enrollment

200 patients

Sex

All

Ages

75 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 75 and over
  • Patients receiving treatment at the day hospital or oncology week hospital
  • Patients informed and having not presented any opposition to their participation

Exclusion criteria

  • Patients under the age of 75
  • Patients under guardianship or curatorship
  • Patients without social security
  • Cognitive disorders compromising the understanding of the information and the performance of the study (in particular the completion of a self-administered questionnaire), in the opinion of the oncologist

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems